Poniard Pharmaceuticals Valuation
Based on Macroaxis valuation methodology, the company cannot be evaluated at this time. Poniard Pharmaceuticals recent Real Value cannot be determined due to lack of data. The prevailing price of Poniard Pharmaceuticals is $0.0. Our model determines the value of Poniard Pharmaceuticals from analyzing the company fundamentals such as Return On Equity of -2.1, shares outstanding of 1.5 M, and Price To Earning of (0.01) X as well as examining its technical indicators and probability of bankruptcy.
Poniard Pharmaceuticals Total Value Analysis
Poniard Pharmaceuticals is at this time projected to have valuation of 434.76 K with market capitalization of 29, debt of 1.57 M, and cash on hands of 1.98 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Poniard Pharmaceuticals fundamentals before making equity appraisal based on enterprise value of the companyTakeover Price | Market Cap | Debt Obligations | Cash |
434.76 K | 29 | 1.57 M | 1.98 M |
Poniard Pharmaceuticals Asset Utilization
One of the ways to look at asset utilization of Poniard is to check how much profit was generated for every dollar of assets it reports. Poniard Pharmaceuticals holds a negative application of assets of -0.46 pct., losing $0.004603 for each dollar of assets held by the company. Inadequate asset utilization implies the company is being less effective with each dollar of assets it holds. Put it differently, asset utilization of Poniard Pharmaceuticals shows how discouraging it operates for each dollar spent on its assets.Poniard Pharmaceuticals Profitability Analysis
Net Loss for the year was (30.05 M) with profit before overhead, payroll, taxes, and interest of 0.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Poniard Pharmaceuticals' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Poniard Pharmaceuticals and how it compares across the competition.
Poniard Pharmaceuticals Growth Indicators
Investing in growth stocks can be very risky. If the company such as Poniard Pharmaceuticals does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Retained Earnings | -438.9 M |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Consideration for investing in Poniard Pink Sheet
If you are still planning to invest in Poniard Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Poniard Pharmaceuticals' history and understand the potential risks before investing.
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |